Members of the tumor necrosis factor receptor superfamily (TNFRSF) participate prominently
in B‐cell maturation and function. In particular, B‐cell activating factor belonging to the TNF …

B-cell maturation antigen (BCMA) plays a critical role in regulating B-cell proliferation and
survival. There is evidence for BCMA expression in various hematologic malignancies …

Here we show that overexpression or activation of B-cell maturation antigen (BCMA) by its
ligand, a proliferation-inducing ligand (APRIL), promotes human multiple myeloma (MM) …

B-cell maturation antigen (BCMA), highly expressed on malignant plasma cells in human
multiple myeloma (MM), has not been effectively targeted with therapeutic monoclonal …

B-cell maturation antigen (BCMA) is a highly plasma cell-selective protein that is expressed
on malignant plasma cells of multiple myeloma (MM) patients and therefore is an ideal target …

The key nuclear export protein CRM1/XPO1 may represent a promising novel therapeutic
target in human multiple myeloma (MM). Here we showed that chromosome region …

Abstract Background BCMA CAR-T is highly effective for relapsed/refractory multiple
myeloma (R/R-MM) and significantly improves the survival of patients. However, the short …

B-cell maturation antigen (BCMA) is a promising therapeutic target for multiple myeloma
(MM), but expression is variable, and early reports of BCMA targeting chimeric antigen …

B‐cell maturation antigen (BCMA, also termed TNFRSF 17) is an attractive therapeutic target
due to its restricted expression on normal and malignant plasma cells (PC). GSK 2857916 …

Bruton tyrosine kinase (Btk) has a well-defined role in B-cell development, whereas its
expression in osteoclasts (OCs) further suggests a role in osteoclastogenesis. Here we …